Illinois Wesleyan University

Digital Commons @ IWU
John Wesley Powell Student Research
Conference

2007, 18th Annual JWP Conference

Apr 14th, 2:35 PM - 3:35 PM

Effects of Dephosphorylation In 7E Mutants of NPR-A
Bridget Wall, '08
Illinois Wesleyan University

Brian Walter, Faculty Advisor
Illinois Wesleyan University

Follow this and additional works at: https://digitalcommons.iwu.edu/jwprc

Wall, '08, Bridget and Walter, Faculty Advisor, Brian, "Effects of Dephosphorylation In 7E
Mutants of NPR-A" (2007). John Wesley Powell Student Research Conference. 2.
https://digitalcommons.iwu.edu/jwprc/2007/posters2/2

This Event is protected by copyright and/or related rights. It has been brought to you by Digital
Commons @ IWU with permission from the rights-holder(s). You are free to use this material in any
way that is permitted by the copyright and related rights legislation that applies to your use. For
other uses you need to obtain permission from the rights-holder(s) directly, unless additional rights
are indicated by a Creative Commons license in the record and/ or on the work itself. This material
has been accepted for inclusion by faculty at Illinois Wesleyan University. For more information,
please contact digitalcommons@iwu.edu.
©Copyright is owned by the author of this document.

THE JOHN WESLEY POWELL STUDENT RESEARCH CONFERENCE - APRIL 2007

Poster Presentation P3, P82

EFFECTS OF DEPHOSPHORYLATION IN 7E MUTANTS OF NPR-A

Bridget Wall and Brian Walter*
Biology Department, Illinois Wesleyan University

Natriuretic peptides (designated ANP, BNP, and CNP) are hormones and paracrine factors which
regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat
metabolism and long bone growth. When bound to natriuretic peptide receptors, they allow for
the production of cGMP (cyclic guanosine monophosphate), a secondary messenger which
allows for the production of proteins from the cell. These receptors are designated NPR-A/GC
A and NPR-B/GC-B. Both are guanylyl cyclases (enzymes that synthesize cGMP). The focus
of this research is to further examine the involvement of dephosphorylation in the desensitization
of natriuretic peptide receptors. Previously, phosphorylation sites on the guanylyl cy1case
domain have been mutated to express glutamate, an amino acid with a charge of - 1 (the charge of
a phosphate is -2). Therefore, the glutamate is mimicking the charge on the phosphoryl at residue
present when the receptor is phosphorylated.
Ergo, these NPR-A mutants (hereafter referred to as 7E mutants) are constitutively
phosphorylated and always active. Within the current model, there should be a significant
difference in cGMP production when stimulated with natriuretic peptides. By continuing
previous studies geared toward a better understanding of phosphorylation in these receptors,
members of the field of pharmocology will be able to develop a drug that will either semi
permanently dephosphorylate or phosphorylate natriuretic peptide receptors in an effort to treat
heart disease and hypertension.

